Tag Archives: SGMO

Monday’s Highlights at Noon: Sangamo Biosciences (SGMO), Quinstreet (QNST), Cormedix Inc (CRMD), CDTi Advanced Materials Inc (CDTI), Nordic American Tanker (NAT)

So far Monday, February 11, NASDAQ is down -0.96% and the S&P is down -0.61%. Here are this morning’s most active stocks: Sangamo Biosciences (SGMO – Research Report), Quinstreet (QNST – Research Report), Cormedix Inc (CRMD – Research Report), CDTi

Thursday’s Midday Movers: Rosetta Genomics Ltd (ROSG), Acura Pharmaceuticals (ACUR), Rex Energy (REXX), Amedica (AMDA), Sangamo Biosciences (SGMO)

So far Thursday, September 6, NASDAQ is down -4.12% and the S&P is down -1.59%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Rosetta Genomics Ltd (NASDAQ:ROSG), Acura Pharmaceuticals (Other OTC:ACUR), Rex Energy

Wednesday’s Highlights at Noon: Rosetta Genomics Ltd (ROSG), Yingli (YGE), MannKind (MNKD), Microvision (MVIS), Sangamo Biosciences (SGMO)

So far Wednesday, September 5, NASDAQ is down -2.23% and the S&P is down -0.06%. Here are this morning’s most active stocks: Rosetta Genomics Ltd (NASDAQ:ROSG), Yingli (NYSE:YGE), MannKind (NASDAQ:MNKD), Microvision (NASDAQ:MVIS) and Sangamo Biosciences (NASDAQ:SGMO). Rosetta Genomics Ltd is

Wedbush Keeps a Hold Rating on Sangamo Biosciences (SGMO)

Wedbush analyst Liana Moussatos reiterated a Hold rating on Sangamo Biosciences (NASDAQ: SGMO) today and set a price target of $10. The company’s shares opened today at $14.80. According to TipRanks.com, Moussatos is a 3-star analyst with an average return

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sangamo Biosciences (NASDAQ: SGMO) and Neurocrine (NASDAQ: NBIX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Sangamo Biosciences (NASDAQ:SGMO) and Neurocrine (NASDAQ:NBIX). Sangamo Biosciences (SGMO) In a report released today, Liana Moussatos from Wedbush reiterated a Hold rating on Sangamo Biosciences,

Sangamo Biosciences Receives a New Rating from Cowen & Co.

Sangamo Biosciences (NASDAQ: SGMO) received a Buy rating from Cowen & Co. analyst Ritu Baral today. The company’s shares opened today at $15.45. According to TipRanks.com, Baral is a top 100 analyst with an average return of 37.6% and a